Exelixis, Storm to collaborate on cancer treatments
Exelixis and Storm Therapeutics have entered into an exclusive collaboration and license agreement to discover and develop new drug leads to treat cancer. Read More
Jackson Laboratory acquires Charles River Laboratories Japan
Biomedical research company the Jackson Laboratory has acquired Charles River Laboratories Japan's Research Models and Services business as a wholly owned subsidiary. Read More
Immusoft, Takeda ink metabolic disorder cell therapy deal
Immusoft has signed a research and licensing deal with Takeda Pharmaceutical to develop cell therapies for rare inherited metabolic disorders that have manifestations in the central nervous system. Read More
IMA Group acquires research site in Texas
The IMA Group has acquired Diagnostics Research Group, a clinical research site in San Antonio, TX. Read More
Dotmatics partners with RockStep Solutions
Scientific informatics software and service firm Dotmatics and RockStep Solutions are partnering to offer a digitized in vivo drug discovery platform. Read More
Twist Bioscience, Broad Institute partner
Twist Bioscience and the Broad Institute have created a custom next-generation sequencing target enrichment exome panel to be used to research cancer and rare and inherited disease genes. Read More
GeneCentric Therapeutics teams up with Labcorp
GeneCentric Therapeutics has formed a strategic partnership with Labcorp to develop and commercialize RNA-based gene signatures for oncology diagnostics. Read More
MilliporeSigma doubles viral vector production with new facility
MilliporeSigma has opened a second contract development manufacturing facility in California to focus on viral vector technologies for cell and gene therapy. Read More
AGTC CEO to present at Cell & Gene Meeting on the Mesa
Biotechnology firm Applied Genetic Technologies (AGTC) President and CEO Sue Washer will present at the Cell & Gene Meeting on the Mesa in Carlsbad, CA, on October 13 at 11:15 a.m. PT. Read More
Mission Bio debuts new capabilities for cell, gene therapy
Mission Bio has unveiled its Tapestri Cell & Gene Therapy Solutions, a new addition to its Tapesti platform that can provide analytical characterization of genotype with phenotype simultaneously. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
